On Wednesday, May 13, the Patent Trial & Appeal Board (“PTAB”) issued an important Inter Partes Review decision in favor of our client, Sorna Corporation, a worldwide leader in medical information sharing solutions. After several years of litigation history, a competitor again tried to invalidate our client’s innovative, industry-leading patents. The decision by the PTAB upheld each of the challenged claims, allowing Sorna to continue to take advantage of its unique patent protections in a very competitive industry.
Alex Farrell led the litigation team, working with Frank Farrell (F.S. Farrell, LLC), in another intellectual property victory for Best & Flanagan clients. Only about 20% of petitions to the PTAB result in all challenged patent claims surviving, as was the case here. Sorna’s Executive Vice President Cyrus Samari noted, “This is a major victory for us – further confirming our innovation. Sorna invested the time and money to secure patent protection in a very dynamic and ever-changing industry. The Board today confirmed that our patents are novel, and that they represent the gold standard for medical data recording devices of this kind.”
Best & Flanagan’s intellectual property attorneys help identify, organize, protect and maximize the value of intellectual property, including patents, copyrights, trademarks and trade secrets. We work with our clients on large and small IP transactions, including state and federal registrations, licensing agreements, content deals, joint ventures and other business relationships, and can bring enforcement actions when our clients' IP rights are violated or challenged. We work hard to give our clients the smartest and most cost-effective counsel that meets their needs and objectives.
Sorna Corporation designs and manufactures DICOM and IHE conformant products that facilitate the sharing, burning, importing, converting, viewing, and storing of medical studies, images, and related documents from a variety of sources, to a multitude of destinations. Since 1999, Sorna has led the way in anticipating the data sharing needs within healthcare. Industry experience and engineering expertise allows Sorna to respond with innovative solutions, making the sharing and management of medical studies easier and more convenient for healthcare professionals.
To read the full decision, please see: Final Written Decision '408 IPR